Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors.
Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors.
Journal: British journal of cancer
Published: December 12, 2022
Randomized Phase 3 Trial of Ruxolitinib for COVID-19-Associated Acute Respiratory Distress Syndrome.
Randomized Phase 3 Trial of Ruxolitinib for COVID-19-Associated Acute Respiratory Distress Syndrome.
Journal: Critical care medicine
Published: October 13, 2022
Characterization of INCB086550: A Potent and Novel Small-Molecule PD-L1 Inhibitor.
Journal: Cancer discovery
Published: August 27, 2021
Acceptance and Commitment Therapy with Pancreatic Cancer: An Integrative Model of Palliative Care-A Case Report.
Journal: Journal of pancreatic cancer
Published: January 12, 2019
RNA-Binding Protein HuR Regulates Both Mutant and Wild-Type IDH1 in IDH1-Mutated Cancer.
Journal: Molecular cancer research : MCR
Published: May 29, 2018
Host IDO2 Gene Status Influences Tumor Progression and Radiotherapy Response in KRAS-Driven Sporadic Pancreatic Cancers.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 21, 2018
Personalized therapy for pancreatic cancer: Do we need better targets, arrows, or both?
Journal: Discovery medicine
Published: March 25, 2016
The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms.
Journal: International journal of biological sciences
Published: March 02, 2016
HER-2-Positive Ampullary Adenocarcinoma: A Case Report.
Journal: Case reports in pancreatic cancer
Published: November 01, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026